Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker.
Preeclampsia is a placental disease characterized by hypertension and proteinuria in pregnant women, and it is associated with a high maternal and neonatal morbidity. However, circulating biomarkers that are able to predict the prognosis of preeclampsia are lacking. Thirty-eight women were included...
Guardado en:
Autores principales: | Julien Textoris, Delphine Ivorra, Amira Ben Amara, Florence Sabatier, Jean-Pierre Ménard, Hélène Heckenroth, Florence Bretelle, Jean-Louis Mege |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b11a33faaba4ba2adb654e6bcbd5f81 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The gene expression analysis of blood reveals S100A11 and AQP9 as potential biomarkers of infective endocarditis.
por: Franck Thuny, et al.
Publicado: (2012) -
Biomarkers for prediction and diagnostics of preeclampsia
por: O. V. Radkov, et al.
Publicado: (2018) -
Placenta-derived exosomes: potential biomarkers of preeclampsia
por: Pillay P, et al.
Publicado: (2017) -
Metabolomic biomarkers in serum and urine in women with preeclampsia.
por: Marie Austdal, et al.
Publicado: (2014) -
Novel blood test for early biomarkers of preeclampsia and Alzheimer’s disease
por: Shibin Cheng, et al.
Publicado: (2021)